Cairo University old website - Children with Ganglia Cancer (Alnaoroblastomo)

Cairo University

Excellence in providing higher education services to meet the needs of the national, regional and international communities, and the effective continuous contribution in achieving Egypt’s social and economic development. Our mission is to be accomplished through a commitment to international standards of excellence in the fields of education, research and community service, as well as the integration of personnel, technology and business systems, and the development of the university’s human resources.

Children with Ganglia Cancer (Alnaoroblastomo)

Date :2013-02-05

PhD. Thesis, by Amr Abdu Allah Salem, entitled "Existence of tyrosine hydroxylase enzyme, and its reference to existence of a minimum of the remnants of the disease in children with ganglia cancer (Alnaoroblastomo) distinguished with high-risk and its impact on the outcome of the treatment after transplanting bone marrow transplantation", has been discussed at National Cancer Institute, Cairo University. It is supervised by Prof. Dr.\ Alaa Mohamed El-Haddad, Prof. Dr.\ Nayera Hamdy El-Shakankiry, Prof. Dr.\ Hala Taha Salem, and Dr.\ Wael Zekry Khaled. Committee of Arbitration and Discussion is composed of Prof. Dr.\ Alaa Mohamed El-Haddad, Prof. Dr.\ Nayera Hamdy El-Shakankiry, Prof. Dr.\ Loubna Mohamed El-Amin, and Prof. Dr.\ Laila Metwally Sherif.

Cairo University